Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prevention of Bacterial Infections in the Newborn by Pre-delivery Administration of Azithromycin (AZI): a Placebo-controlled Randomized Trial

Trial Profile

Prevention of Bacterial Infections in the Newborn by Pre-delivery Administration of Azithromycin (AZI): a Placebo-controlled Randomized Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Mar 2018

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Bacterial infections; Neonatal infections
  • Focus Therapeutic Use
  • Acronyms PregnAnZI
  • Most Recent Events

    • 28 Mar 2018 Results (n=461) assessing long-term impact of oral azithromycin taken by gambian women during labour on prevalence and antibiotic susceptibility of s. pneumoniae and s. aureus in their infants: follow up of a randomized clinical trial were published in the Clinical Infectious Diseases.
    • 08 Oct 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 08 Sep 2014 Planned primary completion date changed from 1 Jun 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top